• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

治疗时机延迟与恶性骨肿瘤转移相关。

Delayed Initiation of Treatment Is Associated With Metastasis of Malignant Bone Tumor.

机构信息

Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan.

Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan

出版信息

Anticancer Res. 2021 Jun;41(6):2993-2999. doi: 10.21873/anticanres.15081.

DOI:10.21873/anticanres.15081
PMID:34083290
Abstract

BACKGROUND/AIM: The delayed initiation of treatment is not associated with good clinical outcomes in patients with malignancies. However, few previous studies have examined prognostic factors, including the delayed initiation of treatment, in malignant bone tumors.

PATIENTS AND METHODS

One hundred and one patients with malignant bone tumors were enrolled. Univariate and multivariate analyses were performed to identify factors predicting metastasis, including factors that delay the initiation of treatment.

RESULTS

The multivariate analysis revealed that high-grade bone malignancy (p<0.01), a >30-day delay in referral to a specialized hospital by a general practitioner (p=0.03), and large tumor size (>77 mm) (p=0.04), were independently associated with metastasis of malignant bone tumors.

CONCLUSION

When general practitioners notice a patient with a >77 mm bone tumor, early referral to a specialized hospital within one month might be essential for preventing metastasis.

摘要

背景/目的:在恶性肿瘤患者中,治疗开始时间的延迟与临床结局不佳无关。然而,以前很少有研究检查包括治疗开始时间延迟在内的恶性骨肿瘤的预后因素。

患者和方法

共纳入 101 例恶性骨肿瘤患者。进行单因素和多因素分析,以确定转移的预测因素,包括延迟治疗开始的因素。

结果

多因素分析显示,高级别骨恶性肿瘤(p<0.01)、全科医生转介至专科医院的时间延迟>30 天(p=0.03)以及肿瘤较大(>77mm)(p=0.04)与恶性骨肿瘤的转移独立相关。

结论

当全科医生发现>77mm 骨肿瘤的患者时,在一个月内尽早将其转介至专科医院可能对预防转移至关重要。

相似文献

1
Delayed Initiation of Treatment Is Associated With Metastasis of Malignant Bone Tumor.治疗时机延迟与恶性骨肿瘤转移相关。
Anticancer Res. 2021 Jun;41(6):2993-2999. doi: 10.21873/anticanres.15081.
2
Delayed Initiation of Treatment Is Associated With Metastasis of Soft-tissue Sarcoma.治疗延迟与软组织肉瘤转移相关。
Anticancer Res. 2020 Dec;40(12):7009-7015. doi: 10.21873/anticanres.14726.
3
Neoadjuvant Chemotherapy Followed by Delayed Surgery: Is it Necessary for All Patients With Nonmetastatic High-Grade Pelvic Osteosarcoma?新辅助化疗后延迟手术:所有非转移性高级骨盆骨肉瘤患者都需要吗?
Clin Orthop Relat Res. 2018 Nov;476(11):2177-2186. doi: 10.1097/CORR.0000000000000387.
4
Improvement in High-Grade Osteosarcoma Survival: Results from 202 Patients Treated at a Single Institution in Taiwan.高分级骨肉瘤生存率的改善:台湾一家机构202例患者的治疗结果
Medicine (Baltimore). 2016 Apr;95(15):e3420. doi: 10.1097/MD.0000000000003420.
5
Prognosis of Primary Osteosarcoma in Elderly Patients: A Comparison between Young and Elderly Patients.老年原发性骨肉瘤的预后:老年患者与年轻患者的比较。
Med Princ Pract. 2019;28(5):425-431. doi: 10.1159/000500404. Epub 2019 Apr 17.
6
The extremity localized classic osteosarcomas have better survival than the axial non-classics.局限性经典型骨外骨肉瘤的存活率高于轴外非经典型。
World J Surg Oncol. 2018 Feb 23;16(1):39. doi: 10.1186/s12957-018-1344-3.
7
[Survival analysis and the effects of prognostic factors in patients treated for osteosarcoma].骨肉瘤患者的生存分析及预后因素的影响
Acta Orthop Traumatol Turc. 2007;41(3):211-9.
8
Update on targets and novel treatment options for high-grade osteosarcoma and chondrosarcoma.高级骨肉瘤和软骨肉瘤的治疗靶点和新型治疗选择的最新进展。
Hematol Oncol Clin North Am. 2013 Oct;27(5):1021-48. doi: 10.1016/j.hoc.2013.07.012. Epub 2013 Aug 26.
9
Telangiectatic osteosarcoma: a review of 87 cases.毛细血管扩张性骨肉瘤:87例病例回顾
J Cancer Res Clin Oncol. 2016 Oct;142(10):2197-207. doi: 10.1007/s00432-016-2210-8. Epub 2016 Jul 28.
10
Vitronectin significantly influences prognosis in osteosarcoma.骨桥蛋白显著影响骨肉瘤的预后。
Int J Clin Exp Pathol. 2015 Sep 1;8(9):11364-71. eCollection 2015.

引用本文的文献

1
Odds of Metastatic Disease at Diagnosis of Primary Bone and Soft-Tissue Sarcomas of the Extremity and Pelvis Based on Preferred Language and Socioeconomic Factors.基于首选语言和社会经济因素的四肢及骨盆原发性骨肉瘤和软组织肉瘤诊断时发生转移性疾病的几率。
J Am Acad Orthop Surg. 2025 Mar 15;33(6):319-326. doi: 10.5435/JAAOS-D-24-00634. Epub 2024 Dec 27.
2
A validation study for the utility of serum microRNA as a diagnostic and prognostic marker in patients with osteosarcoma.一项关于血清微小RNA作为骨肉瘤患者诊断和预后标志物效用的验证研究。
Oncol Lett. 2023 Apr 13;25(6):222. doi: 10.3892/ol.2023.13808. eCollection 2023 Jun.
3
Primary Osteosarcoma in Patients Over 75 Years of Age: A Case Series and Literature Review.
75 岁以上患者的原发性骨肉瘤:病例系列及文献回顾。
In Vivo. 2022 Nov-Dec;36(6):2899-2909. doi: 10.21873/invivo.13031.